May 06, 2020
Oncopeptides has completed a directed share issue raising approximately SEK 1,414 million (USD 144 M)
Media
May 06, 2020
Targovax announces that abstract on interim phase I clinical data from the phase I/II peritoneal trial is accepted at ASCO
May 06, 2020
Q1 2020 General Market Overview
May 05, 2020
Pulmonx Secures $66M in Financing to Support Commercial Acceleration of the Zephyr Valve System, a Minimally-Invasive Treatment for Severe Emphysema
May 05, 2020
Oncopeptides intends to carry out a directed share issue
May 05, 2020
Vicore Pharma receives regulatory approval to start phase II clinical trial with VP01 (C21) in patients with IPF
May 05, 2020
Interim report January – March 2020
May 05, 2020
Nordic Nanovector Announces US Patent Granted Covering the Use of Betalutin® to Sensitise B-Cell Cancer Cells to CD20 Immunotherapy
May 04, 2020
Nordic Nanovector Announces Changes to its Executive Management Team
May 04, 2020
Vicore offers advance voting in connection with the 2020 AGM
